美高梅(MGM.US)與保利文化達成全面藝術文化協定 擬共建文化藝術博物館
美高梅與保利文化昨日(7日)簽署文化藝術項目總體合作協議書,將聯合落地重量級的國際前沿文化藝術博物館,當中保利文化將為藝術博物館項目提供高品質的展覽策劃和藝術品展示服務,據悉藝術博物館的首次展覽將以「海上絲綢之路」為主題。
保利集團董事張浩表示,雙方的合作是一次共同推動澳門與內地的文化交流,亦是推進中華文化繁榮發展的成功實踐。
美高梅中國(02282.HK)董事長兼執行董事何超瓊指,此次合作開啟了內地與澳門跨界文化聯動的新篇章,期望打造出以絲路文化為核心的國際綜合文藝樞紐,預料藝術博物館承載雙方「傳承中創新」的理念,聚焦文化內容與科技的深度結合,開創文化創新的全新實踐平台。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.